Tag: pharmaceuticals
-
Natural, Engineered Microbes Shown to Control Cholera
A combination of natural bacteria found in milk products and a synthetic variation of those microbes are shown in tests with lab mice to detect and prevent cholera infections.
-
Hospital Network Formed for Childhood Cancer Immunotherapies
A network of academic children’s medical centers is being formed to expand access to clinical trials testing immunotherapy treatments for childhood cancer.
-
FDA Issues Guidance on Patient Experience Data Collection
The Food and Drug Administration issued draft regulatory guidance outlining methods for collecting data from patients that the agency says will help improve evaluations of more precisely targeted drugs.
-
$850M Deal Kicks Off RNA Vaccine Research
Drug maker Sanofi is partnering with biotechnology company Translate Bio to develop vaccines against infectious diseases from messenger RNA, material transcribed from genetic codes in DNA.
-
NIH, Biotech Partner on Electro-Aided Crispr for Sickle Cell
The National Heart, Lung, and Blood Institute and a biotechnology company are testing genome editing with electronically treated cells as a therapy for sickle cell disease.
-
Single Technology Produces Vaccines for Multiple Infectious Diseases
A single technology platform is being used to design and produce vaccines that in tests with lab animals protect against a number of infectious diseases.
-
Bacterial Genome Recoded to Produce Stable Protein Drugs
A biotechnology lab devised techniques for genetically engineered bacteria to produce synthetic proteins that can last longer and are more stable than current protein production methods.
-
Stem Cell Transplants Found Safe for Spinal Cord Injuries
Results from a clinical trial testing transplants of neural stem cells for spinal cord injuries show the therapies are safe for patients, with signs of improvement in most participants 1 to 2 years after treatment.
-
Data Tools Designed for Genomics-Based Precision Cancer Care
A computerized system is available that analyzes the genomic composition of cancer patients and recommends personalized treatments that its designers say take into account a larger array of factors than comparable systems.
-
FDA Delays Crispr Trial for Inherited Blood Diseases
The U.S. Food and Drug Administration put a hold on beginning a clinical trial of the emerging genome editing technique known as Crispr to treat inherited blood disorders.